13
Participants
Start Date
February 28, 2009
Primary Completion Date
August 31, 2011
Study Completion Date
August 31, 2011
Resveratrol
Group A: resveratrol 1000 mg (500 mg twice) daily for 1 week then by tolerance and safety 2000 mg (1 000mg twice) daily for 3 weeks, followed by no medication for two weeks and then placebo for twice daily for 4 weeks.
placebo
Participants will receive placebo daily for 4 weeks, followed by no medication for two weeks and then resveratrol 1 000 mg(500 mg twice) daily for 1 week, then by tolerance and safety 2 000 mg (1 000 mg twice) daily for three weeks.
The Ottawa Hospital -General Campus, Ottawa
Lead Sponsor
Ottawa Hospital Research Institute
OTHER